Trials / Completed
CompletedNCT04198207
The Effectiveness and Safety of Vagus Nerve Stimulation for TRE
Clinical Evaluation of the Effectiveness and Safety of Vagus Nerve Stimulation for Tuberous Sclerosis Complex Related Epilepsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Beijing Children's Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective cohort studies to identify clinical epilepsy control, cognitive changes, and safety of VNS in patients with tuberous sclerosis complex-related epilepsy.
Detailed description
This study aims to evaluate the efficacy and safety of vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy in patients with Tuberous Sclerosis Complex (TSC) and compare it with traditional antiepileptic drug therapy. By assessing seizure frequency, severity, and improvements in quality of life, the study seeks to provide evidence-based guidance for clinical treatment strategies.
Conditions
Timeline
- Start date
- 2019-12-10
- Primary completion
- 2024-12-10
- Completion
- 2024-12-10
- First posted
- 2019-12-13
- Last updated
- 2024-12-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04198207. Inclusion in this directory is not an endorsement.